Latest Industry Projects

Our List of Pharmaceutical Projects helps to drive insights-driven action and Pharma execution for superior ROI and they include Pharmaceutical Industry Featured Projects, Upcoming Projects in Pharmaceutical and so on. We provide Global Pharmaceuticals Industry Projects to our clients to ensure efficiencies and effectiveness in their business efforts. Moreover, Pharmaceutical Industry projects leverage cross-channel integration to engage the consumers, generate insights, and measure business value.

Kaneka Eurogentec Plans to Construct New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility in Belgium

Introduction: Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO) announced the construction of a new state of-the-art GMP facility. Features: The expansion will allow for the large scale production of biopharmaceuticals including recombinant proteins, antibody fragments and plasmid DNA. The multi-product facility will include…

GSK Plans to Invest More Than £140 Million on UK Manufacturing Network

Introduction: GSK plans to improve the efficiency and competitiveness of its manufacturing network with an investment of £140 Million. Features: These include both investments for respiratory and HIV medicines manufacturing in the UK and strategic reviews, including the sale of several products and a proposal to close a UK manufacturing…

Patheon to invest $45 million in spray drying & manufacturing solutions

Introduction: Patheon N.V., a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical sector plans to invest $45 million at key sites across its global network to meet growing customer demand for expanded service capabilities. Features: As outsourcing of Pharma development and manufacturing services continues to…

GSK to Invest $139 Million to expand production capacity for BENLYSTA (belimumab) in Rockville, Maryland

Introduction: GSK announced $139 million of investment in its biopharmaceutical manufacturing site in Rockville, MD to support growing demand for BENLYSTA® (belimumab) for adult patients with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy. Features: The Rockville site is also expected to house production of a new…

Apotex to Invest $184 Million for Expansion of R&D, Manufacturing, and Packaging Facility in United States

Introduction: Apotex Inc., the largest Canadian owned pharmaceutical company plans $184 million U.S. expansion plan, including the development of a new R&D center and advanced manufacturing and packaging facility that will serve as the U.S. headquarters for Apotex Corp. and the U.S. offices for Apobiologix. Features: The company chose this…

West-Ward Pharmaceuticals Plans to Expand its Production Plant in Columbus, Ohio

Introduction: West-Ward Pharmaceuticals Corp., one of the leading generic prescription medication providers in the U.S. and a wholly owned subsidiary of Hikma PLC, plans to expand its existing production center in Columbus, Ohio. Features: The expansion will allow the company to accommodate new and expanding product lines. West-Ward also has…

Takeda Pharmaceutical Company Limited Invests €40 Million for New Production Facility in Dublin

Introduction: Takeda Pharmaceutical Company Limited announced plans to invest €40m in a new facility at their Grange Castle site in Dublin. Features: This Investment by Takeda will expand their Grange Castle site’s existing footprint, with the construction of a new standalone high containment production facility dedicated to manufacturing its oncology…

BD Invests $100 Million to Expand Insulin Syringe Manufacturing at Nebraska Plant

Introduction: BD (Becton, Dickinson and Company), a leading global medical technology company announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its insulin syringe manufacturing operations. Features: The investment will be used for new technology and manufacturing equipment to expand capacity for BD insulin…

EMD Serono to Invest $12 Million to Expand Biopharmaceutical R&D Facility in Billerica, Massachusetts

Introduction: EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in North America, today announced a $12 million investment for the expansion of its R&D facility in Billerica, Massachusetts. Features: The new building will span more than 30,000 square feet and accommodate approximately 120 new and current employees whose…

Merck Invests €50 Million in Pharmaceutical Packaging Building in Darmstadt, Germany

Introduction: Merck, a leading science and technology company, announced an investment of more than €50 million in a state-of-the-art packaging building at its pharmaceutical manufacturing site in Darmstadt, Germany. Features: With its state-of-the art, flexible and modern technology, this new center of excellence will enable the packaging of more than…

loadmore..